2-[3-(1,7a-Dihydrobenzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 2-[3-(1,7a-Dihydrobenzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate
• 英文别名: 2-[3-(1,7a-dihydrobenzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate
• 化学式: C₁₈H₁₉N₃O₃
• 分子量: 325.4
• InChiKey: YMYNBJUGKBQGHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  74.2
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• [EN] OPHTHALMIC DEVICES CONTAINING TRANSITION METAL COMPLEXES AS HIGH ENERGY VISIBLE LIGHT FILTERS<br/>[FR] DISPOSITIFS OPHTALMIQUES CONTENANT DES COMPLEXES DE MÉTAUX DE TRANSITION EN TANT QUE FILTRES DE LUMIÈRE VISIBLE À HAUTE ÉNERGIE
  申请人：JOHNSON & JOHNSON VISION CARE

  公开号：WO2021186296A1

  公开（公告）日：2021-09-23

  Described are ophthalmic devices and methods for their preparation and use. The ophthalmic device comprises at least one heterocyclic ligand complexed with a transition metal, wherein the ophthalmic device is a polymerization reaction product of a reactive mixture comprising: (a) one or more monomers suitable for making the ophthalmic device; and (b) a heterocyclic ligand-containing monomer, and wherein the ophthalmic device has a transmittance at 400 nm of 90 percent or less.